Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATILA: Aspirin Versus Tirofiban in Endovascular Treatment for Acute Ischemic Stroke Due to Tandem Lesion
2023-508454-26-00Phase 4Completed
- Sponsor
- Fundación Pública Andaluza para la Gestión de la Investigación
- Start
- Apr 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in ischemic stroke comparing Tirofiban arm with Intravenous aspirin arm (2 arms). Primary endpoints: Carotid reocclusion, Platelet aggregation phenomena and 1 more. Started Apr 2024; status: completed.
02
Drugs
tirofibanaspirin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on 2023-508454-26-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-508454-26-00.